Tuesday 29 September 2015

Global Cervical Cancer Market Forecasts 2015-2019


Cervical cancer is the abnormal growth of cancerous cells in the tissues of the cervix. It is the world's fourth most common cause of death in women. The disease can be classified as squamous cell carcinoma and adenocarcinoma. Squamous cell carcinoma originates in the lining of the cervix, while adenocarcinoma arises in cervical cells. Cervical cancer is caused due to the infection of HPV. There are no signs and symptoms to identify the early stages of cervical cancer, but it can be identified through regular check-ups. Vaginal bleeding and pelvic pain are usually observed as signs and symptoms of cervical cancer. Before cancer detected in the cervix, cervix cells go through changes, called as dysplasia, in which abnormal cells start to expose in the cervical tissue. Over a period, the abnormal cells may developed into cancer cells and begin to grow and spread more deeply into the cervix and surrounding areas.

Technavio's analysts forecast the global cervical cancer market to grow at a CAGR of 4.87% over the period 2014-2019.


Covered in this Report
The report covers the current scenario and the growth prospects of the global cervical cancer market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of various drugs used in the treatment and prevention of cervical cancer.

Table Of Content

PART 01: Executive summary
 Highlights

PART 02: Scope of the report
 Market overview
 Top-vendor offerings

Request A Sample copy of This Report @ http://www.hexareports.com/sample/48252

PART 03: Market research methodology
 Research methodology
 Economic indicators

PART 04: Introduction
 Key market highlights

PART 05: Disease overview
 Understanding the disease
 Risk factors
 Signs and symptoms
 Screening
 Diagnosis
 Staging
 Treatment
 Epidemiology

PART 06: Market landscape
 Market overview
 Market size and forecast
 Five forces analysis

PART 07: Market segmentation by application
 Global prophylactic vaccines market
 Global therapeutic drugs market

PART 08: Market segmentation by type of therapy
 Global cervical cancer therapeutics market by type of therapy
 Chemotherapy
 Targeted therapy
 HPV vaccines

PART 09: Geographical segmentation

PART 10: Key brand analysis

PART 11: Pipeline portfolio

PART 12: Market drivers

PART 13: Impact of drivers

PART 14: Market challenges

PART 15: Impact of drivers and challenges


About Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Information:

Ryan Shaw

Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
1-800-489-3075

No comments:

Post a Comment